121 – 130 of 365
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
-
Mark
Plasma lipid fatty acid composition, desaturase activities and insulin sensitivity in Amerindian women
(
- Contribution to journal › Article
-
Mark
Synergism by individual macronutrients explains the marked early GLP-1 and islet hormone responses to mixed meal challenge in mice.
(
- Contribution to journal › Article
-
Mark
Vildagliptin Reduces Glucagon during Hyperglycemia and Sustains Glucagon Counterregulation during Hypoglycemia in Type 1 Diabetes.
(
- Contribution to journal › Article
-
Mark
The hyperstimulated beta-cell: prelude to diabetes?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Varning för okritisk användning av överviktskirurgi vid typ 2-diabetes.
(
- Contribution to journal › Article
- 2011
-
Mark
GLP-1 for type 2 diabetes
(
- Contribution to journal › Scientific review
-
Mark
Are Sulfonylureas Less Desirable Than DPP-4 Inhibitors as Add-on to Metformin in the Treatment of Type 2 Diabetes?
(
- Contribution to journal › Article
-
Mark
The dynamic incretin adaptation and type 2 diabetes.
(
- Contribution to journal › Article
-
Mark
Reply to the letter by P. Guillausseau Regarding "Sulfonylureas or Dipeptidyl Peptidase (DPP-4) Inhibitors in the Management of Type 2 Diabetes: Debate Is Not Yet Closed"
(
- Contribution to journal › Article
-
Mark
The future of incretin-based therapy: novel avenues-novel targets.
(
- Contribution to journal › Article